Related Experiment Video
Updated: Jun 18, 2025
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
12.4K
Promise and Perils of Primary HPV Testing
Jennifer C Spencer1,2, Cosette M Wheeler3,4,5
1Department of Population Health, Dell Medical School, University of Texas at Austin, Austin, Texas.
Summary
Extending cervical cancer screening intervals to 8 years after a negative human papillomavirus (HPV) test is as safe as current methods. This finding supports longer screening schedules for better resource allocation in cancer prevention.
Area of Science:
- Gynecology
- Oncology
- Public Health
Background:
- Cervical cancer screening significantly reduces disease burden.
- Optimizing screening methods and schedules remains a key research area.
- Human papillomavirus (HPV) testing is an evolving primary screening modality.
Purpose of the Study:
- To evaluate the risk of precancerous cervical disease 8 years after a negative HPV test.
- To compare HPV testing intervals with the standard Pap test schedule.
- To inform evidence-based adjustments to cervical cancer screening guidelines.
Main Methods:
- Analysis of data from a randomized trial in British Columbia, Canada.
- Integration of trial data with a provincial screening registry.
- Risk assessment for cervical intraepithelial neoplasia grades 2 or worse.
Main Results:
- The 8-year risk of precancerous disease after a negative HPV test was comparable to 3-year Pap testing.
- Findings support extending screening intervals beyond the current 5-year recommendation for HPV-positive individuals.
- Potential for resource reallocation to improve screening equity.
Conclusions:
- Primary HPV testing allows for extended screening intervals.
- Implementation challenges exist in fragmented healthcare systems.
- Addressing barriers and improving health information systems are crucial for equitable HPV testing adoption.
More Related Videos
Related Concept Videos
01:13Sensitivity, Specificity, and Predicted Value
241
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
241
01:26Sexually Transmitted Infections
292
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
292
01:30Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347